.

Flexible Flat-Rate Plans

Flat-rate pricing for predictable budgeting

Short-term plans for project- or client-based billing

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Nesiritide recombinant - Generic Drug Details

« Back to Dashboard
Nesiritide recombinant is the generic ingredient in one branded drug marketed by Scios Llc and is included in one NDA. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for nesiritide recombinant. One supplier is listed for this compound.

Summary for Generic Name: nesiritide recombinant

Tradenames:1
Patents:0
Applicants:1
NDAs:1
Drug Master File Entries: see list2
Suppliers / Packaging: see list1

Pharmacology for Ingredient: nesiritide recombinant

Clinical Trials for: nesiritide recombinant

Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Scios Llc
NATRECOR
nesiritide recombinant
FOR SOLUTION;INTRAVENOUS020920-001Aug 10, 2001RXYes<disabled><disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: nesiritide recombinant

These historical archives are available as an add-on to one-year subscriptions.
See the Signup Form for more information.

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Scios Llc
NATRECOR
nesiritide recombinant
FOR SOLUTION;INTRAVENOUS020920-001Aug 10, 20015,114,923<disabled>
Scios Llc
NATRECOR
nesiritide recombinant
FOR SOLUTION;INTRAVENOUS020920-001Aug 10, 20016,974,861<disabled>
Scios Llc
NATRECOR
nesiritide recombinant
FOR SOLUTION;INTRAVENOUS020920-001Aug 10, 20015,674,710<disabled>
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

How are People Using DrugPatentWatch?

`abc